Genetic Screening of the Lipoprotein Lipase Gene for Mutations in Chinese Subjects with or without Hypertriglyceridemia

Department of Biochemistry, Tianjin Medical University, Tianjin 300070, China

More Information

Corresponding author: E-mail address: tjxieyh@sina.com (Yonghong Xie)

摘要

- /
- /
- /
Abstract: Objective: To investigate the association between the mutations in lipoprotein lipase gene and hypertriglyceridemia (HTG). Methods: The lipoprotein lipase (LPL) gene was screened for mutations in 386 Chinese subjects with (108 cases in the HTG group) or without HTG (278 cases in the control group), by single-strand conformation polymorphism (SSCP) analysis and DNA sequencing. Results: One novel silent mutation L103L, one missense mutation P207L, three splicing mutations Int3/3′-ass/C(-6) → T, and the common S447X polymorphism has been identified in the whole coding region and exon-intron junctions of the LPL gene were examined. Heterozygous P207L found in the HTG group was the first case reported in Asia and subsequently another P207L heterozygote was found in the proband's family, all of which suggested that P207L was one of the causes of familial combined hyperlipidemia, but was not so prevalent as that in French Canadian. Int3/3′-ass/C(-6) → T was found in both groups in the present study although it was regarded as a pathogenic variant to HTG earlier on. Moreover about the beneficial polymorphism S447X, there was also some supportive evidence that the levels of triglycerides (TG) in S447X carriers were significantly lower than noncarriers in the subjects without HTG. Conclusions: The association between theLPL variants and HTG is quite complicated and versatile, genotyping of LPL in a larger-scale screening should be necessary and justifiable.
- lipoprotein lipase /
- mutations /
- Chinese /
- hypertriglyceridemia

HTML全文

参考文献(34)

[1]	Scriver, CR, Beaudet, et al.
[2]	Merkel, M, Eckel, et al. Lipoprotein lipase: genetics, lipid uptake and regulation J Lipid Res, 43 (2002),pp. 1997-2006
[3]	Deeb, SS, Peng, et al. Structure of the human lipoprotein lipase gene Biochemistry, 28 (1989),pp. 4131-4135
[4]	Golderg, IJ Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis J Lipid Res, 37 (1996),pp. 693-707
[5]	Williams, KJ, Tabas, et al. The response to retention hypothesis of early atherogenesis Arterioscler Thromb Vasc Biol, 15 (1995),pp. 551-561
[6]	Wu, DA, Bu, et al. Quantitative trait locus mapping of human blood pressure to a genetic region at or near the lipoprotein lipase gene locus on chromosome 8p22 J Clin Invest, 97 (1996),pp. 2111-2118
[7]	Sprecher, DL, Harris, et al. Higher triglycerides, lower high-density lipoprotein cholesterol, and higher systolic blood pressure in lipoprotein lipase-deficient heterozygotes. A preliminary report Circulation, 94 (1996),pp. 3239-3245
[8]	Nicklas, BJ, Ferrell, et al. Lipoprotein lipase gene variation is associated with adipose tissue lipoprotein lipase activity, and lipoprotein lipid and glucose concentrations in overweight postmenopausal women Hum Genet, 106 (2000),pp. 420-424
[9]	Ko, YL, Ko, et al. Interaction between obesity and genetic polymorphisms in the apolipoprotein CIII gene and lipoprotein lipase gene on the risk of hypertriglyceridemia in Chinese Hum Genet, 100 (1997),pp. 327-333
[10]	Lahiri, Dk, Schnabel, et al. Biochem Genet, 31 (1993),pp. 321-325
[11]	Oka, K, Tkalcevic, et al. Structure and polymorphic map of human lipoprotein lipase gene Biochim Biophys Acta, 1049 (1990),pp. 21-26
[12]	Ma, Y, Henderson, et al. A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in French Canadians N Engl J Med, 324 (1991),pp. 1761-1766
[13]	Ruel, IL, Gaudet, et al. Characterization of LDL particle size among carriers of a defective or a null mutation in the lipoprotein lipase gene-he Québec LIPD Study Arterioscler Thromb Vasc Biol, 22 (2002),pp. 1181-1186
[14]	Zhang, AH, Liu, et al. Determination of lipoprotein lipase activity using radioactive substrate emulsion and its application Zhong Guo Dong Mai Ying Hua Za Zhi, 11 (2003),pp. 573-576
[15]	Van Tilbeurgh, H, Roussel, et al. Lipoprotein lipase. Molecular model based on the pancreatic lipase X-Ray structure: Consequences for heparin binding and catalysis J Biol Chem, 269 (1994),pp. 4626-4633
[16]	Semenkovich, CF, Chen, et al. Lipoprotein lipase and hepatic lipase mRNA tissue specific expression, developmental regulation and evolution J Lipid Res, 30 (1989),pp. 423-431
[17]	Mailly, F, Palmen, et al. Hum Mutat, 10 (1997),pp. 465-473
[18]	Peterson, J, Ayyobi, et al. Structural and functional consequences of missense mutations in exon 5 of the lipoprotein lipase gene J Lipid Res, 43 (2002),pp. 398-406
[19]	Maruyama, T, Yamashita, et al. Mutations in Japanese subjects with primary hyperlipidemia-results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996 J Atheroscler Thromb, 11 (2004),pp. 131-145
[20]	Chan, LYS, Lam, et al. Hum Mutat, 20 (2002),pp. 232-233
[21]	Hata, A, Emi, et al. Compound heterozygote for lipoprotein lipase deficiency: Ser→Thr244 and transition in 3′ splice site of intron 2 (AG→AA) in the lipoprotein lipase gene Am J Hum Genet, 47 (1990),pp. 721-726
[22]	Gotoda, T, Yamada, et al. Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency J Clin Invest, 88 (1991),pp. 1856-1864
[23]	Chimienti, G, Capurso, et al. A G→C change at the donor splice site of intron 1 causes lipoprotein lipase deficiency in a southern-Italian family Biochem Biophys Res Commun, 187 (1992),pp. 620-627
[24]	Nakamura, T, Suehiro, et al. A novel nonsense mutation in exon 1 and a transition in intron 3 of the lipoprotein lipase gene J Atheroscler Thromb, 3 (1996),pp. 17-24
[25]	Li, J, Kobori, et al. The application of end user computing (EUC) for detection of lipoprotein lipase gene abnormality Rinsho Byori, 47 (1999),pp. 737-743
[26]	Zhao, YS, Yang, et al. Hereditas,(Beijing), 24 (2002),pp. 519-522
[27]	Yang, T, Pang, et al. Pathogenic mutations of the lipoproteinlipase gene in Chinese patients with hypertriglyceridemic type 2 diabetes Hum Mutat, 21 (2003),pp. 453-457
[28]	Humphries, SE, Nicaud, et al. Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides-the european atherosclerosis research study (EARS) Arterioscler Thromb Vasc Biol, 18 (1998),pp. 526-534
[29]	Wittrup, HH, Tybjærg-Hansen, et al. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease-A Meta-analysis Circulation, 99 (1999),pp. 2901-2907
[30]	Zhao, SP, Tong, et al. The lipoprotein lipase Ser447Ter mutation and risk of stroke in the Chinese Clin Chim Acta, 330 (2003),pp. 161-164
[31]	Gagne, SE, Larson, et al. A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham offspring study Clin Genet, 55 (1999),pp. 450-454
[32]	Evans, V, Kastelein, et al. Lipoprotein lipase deficiency—Rare or common? Cardiovasc Drugs Ther, 16 (2002),pp. 283-287
[33]	Ma, Y, Ooi, et al. High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform J Lipid Res, 35 (1994),pp. 1066-1075
[34]	Xin, X, Srinivasan, et al. Interaction effect of Serine447Stop variant of the lipoprotein lipase gene and C-514T variant of the hepatic lipase gene on serum triglyceride levels in young adults: the Bogalusa heart Study Metabolism, 52 (2003),pp. 1337-1342